2,097 reports of this reaction
3.6% of all HYDRALAZINE HYDROCHLORIDE reports
#3 most reported adverse reaction
RENAL FAILURE is the #3 most commonly reported adverse reaction for HYDRALAZINE HYDROCHLORIDE, manufactured by Nivagen Pharmaceuticals, Inc.. There are 2,097 FDA adverse event reports linking HYDRALAZINE HYDROCHLORIDE to RENAL FAILURE. This represents approximately 3.6% of all 59,065 adverse event reports for this drug.
Patients taking HYDRALAZINE HYDROCHLORIDE who experience renal failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RENAL FAILURE is moderately reported among HYDRALAZINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to renal failure, the following adverse reactions have been reported for HYDRALAZINE HYDROCHLORIDE:
The following drugs have also been linked to renal failure in FDA adverse event reports:
RENAL FAILURE has been reported as an adverse event in 2,097 FDA reports for HYDRALAZINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RENAL FAILURE accounts for approximately 3.6% of all adverse event reports for HYDRALAZINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience renal failure while taking HYDRALAZINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.